Novo will exit the musculoskeletal disease drug developer, should the latter complete an initial public offering on the Nasdaq Global Market.

SR One is line for an exit from the small-molecule therapy developer, which has raised $170m in venture funding in the past year.

Hyundai, Kia and existing investor GV are contributing to a $350 PIPE in support of a reverse takeover that will value the merged company at $2bn.

The PayPal-backed food ordering software provider is slated to raise between $228m and $324m after setting a range for its initial public offering.

Kuaishou, Tencent, Sogou, Baidu and Sunshine Life are in line to exit the online answer platform developer, valued above $3.4bn in its last funding round.

The Tencent-backed internet-of-things platform developer has chosen the New York Stock Exchange for its initial public offering.

University of Pennyslvania and Caltech are in line for exits when Stanford’s online education spinout lists on the New York Stock Exchange.

Seek Group, Times Internet and Laureate Education are all in line for exits when the Stanford University online education spinout lists on the New York Stock Exchange.

Ping An and Alphabet-backed health insurer Oscar priced an upsized offering above its range to raise $1.44bn. The offering is part of the broader health space, which has seen many exits in the past years.

Immuno-oncology therapy developer Lava Therapeutics has filed for a $100m IPO, having been set up in 2016 to exploit Amsterdam University Medical Centers research.